In Situ Dendritic Cell Recruitment and T Cell Activation for Cancer Immunotherapy
Cancer immunotherapy has shifted the paradigm for cancer treatment in the past decade, but new immunotherapies enabling the effective treatment of solid tumors are still greatly demanded. Here we report a pore-forming hydrogel-based immunotherapy that enables simultaneous recruitment of dendritic ce...
Main Authors: | Joonsu Han, Rimsha Bhatta, Yusheng Liu, Yang Bo, Hua Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.954955/full |
Similar Items
-
Dendritic Cell-Based Immunotherapy in Hot and Cold Tumors
by: Byeong Hoon Kang, et al.
Published: (2022-06-01) -
Targeted delivery of liposomal chemoimmunotherapy for cancer treatment
by: Yusheng Liu, et al.
Published: (2022-10-01) -
Development of Cell Technologies Based on Dendritic Cells for Immunotherapy of Oncological Diseases
by: Vasily Kurilin, et al.
Published: (2024-03-01) -
Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine
by: Joonsu Han, et al.
Published: (2023-08-01) -
Dendritic Cells in Cancer Immunology and Immunotherapy
by: Laura Hato, et al.
Published: (2024-02-01)